Undag, Alma S.
HRN: 13-88-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2025
CEFTRIAXONE 1G (VIAL)
08/19/2025
08/26/2025
IV
2g
OD
Bilateral Pneumonia
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines